7,8-Dichloroquinoline

Catalog No.: 
ACVPNX643
CAS No.: 
703-49-1
Molecular Formula: 
C9H5Cl2N
Molecular Weight: 
198.05
7,8-Dichloroquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$117.00InquiryInquiry
1g98%$253.00InquiryInquiry
5g98%$720.00InquiryInquiry
10g98%$953.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7,8-Dichloroquinoline
IUPAC Name7,8-dichloroquinoline
MDL No.D186133
Molecular FormulaC9H5Cl2N
Molecular Weight198.05
SMILESClC1=C2N=CC=CC2=CC=C1Cl
InChI KeyBQNIWGUGRICGFJ-UHFFFAOYSA-N
Synonym7,8-DICHLOROQUINOLINE | 703-49-1 | DTXSID00601697 | SMSSF-0625294 | MFCD12026044 | AKOS006315833 | SB68230 | AMS_CNC_ID-1069585134 | BS-29363 | CS-0211040 | EN300-1666412 | A866627 | Z1198342782
CAS No.703-49-1
PubChem CID19987583

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACVPNX643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVPNX643 route product structure diagram
    ACVPNX643703-49-1
Inquiry

2. ACVPNX643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVPNX643 route product structure diagram
    ACVPNX643703-49-1
Inquiry

3. ACVPNX643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVPNX643 route product structure diagram
    ACVPNX643703-49-1
Inquiry

Comments (0)